A detailed history of Jag Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Jag Capital Management, LLC holds 1,005 shares of AMGN stock, worth $265,531. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,005
Previous 1,003 0.2%
Holding current value
$265,531
Previous $313,000 3.19%
% of portfolio
0.04%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$309.38 - $337.38 $618 - $674
2 Added 0.2%
1,005 $323,000
Q2 2024

Jul 30, 2024

SELL
$262.75 - $319.31 $51,761 - $62,904
-197 Reduced 16.42%
1,003 $313,000
Q1 2023

Sep 07, 2023

SELL
$225.79 - $275.2 $67,737 - $82,560
-300 Reduced 20.0%
1,200 $290,000
Q1 2023

Sep 01, 2023

SELL
$225.79 - $275.2 $67,737 - $82,560
-300 Reduced 20.0%
1,200 $290,000
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $85,122 - $103,750
-377 Reduced 23.91%
1,200 $290,000
Q4 2022

Sep 07, 2023

BUY
$229.03 - $291.01 $68,709 - $87,303
300 Added 25.0%
1,500 $393,000
Q4 2022

Sep 01, 2023

BUY
$229.03 - $291.01 $68,709 - $87,303
300 Added 25.0%
1,500 $393,000
Q2 2022

Aug 01, 2022

SELL
$230.71 - $256.74 $505,716 - $562,774
-2,192 Reduced 58.16%
1,577 $384,000
Q1 2022

May 11, 2022

BUY
$219.27 - $242.57 $563,304 - $623,162
2,569 Added 214.08%
3,769 $938,000
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $503,763 - $576,510
-2,533 Reduced 67.85%
1,200 $270,000
Q3 2021

Oct 21, 2021

SELL
$212.27 - $248.7 $9,976 - $11,688
-47 Reduced 1.24%
3,733 $794,000
Q2 2021

Jul 23, 2021

BUY
$233.58 - $259.14 $2,569 - $2,850
11 Added 0.29%
3,780 $921,000
Q1 2021

Apr 23, 2021

BUY
$221.91 - $258.6 $221 - $258
1 Added 0.03%
3,769 $938,000
Q4 2020

Feb 01, 2021

SELL
$216.38 - $257.67 $20,556 - $24,478
-95 Reduced 2.46%
3,768 $866,000
Q3 2020

Oct 21, 2020

BUY
$234.65 - $260.95 $11,967 - $13,308
51 Added 1.34%
3,863 $982,000
Q2 2020

Jul 23, 2020

SELL
$197.81 - $242.74 $25,517 - $31,313
-129 Reduced 3.27%
3,812 $899,000
Q1 2020

Apr 16, 2020

SELL
$182.24 - $241.7 $150,165 - $199,160
-824 Reduced 17.29%
3,941 $799,000
Q4 2019

Jan 27, 2020

BUY
$189.21 - $243.2 $17,028 - $21,888
90 Added 1.93%
4,765 $1.15 Million
Q3 2019

Oct 24, 2019

BUY
$174.11 - $208.62 $614,608 - $736,428
3,530 Added 308.3%
4,675 $905,000
Q2 2019

Jul 22, 2019

BUY
$166.7 - $195.41 $7,501 - $8,793
45 Added 4.09%
1,145 $211,000
Q2 2018

Jul 20, 2018

BUY
$166.05 - $186.51 $182,655 - $205,161
1,100 New
1,100 $203,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jag Capital Management, LLC Portfolio

Follow Jag Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jag Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jag Capital Management, LLC with notifications on news.